Oxford BioMedica PLC
LSE:OXB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oxford BioMedica PLC
LSE:OXB
|
UK |
|
Daito Trust Construction Co Ltd
TSE:1878
|
JP |
|
Modern Internasional Tbk PT
IDX:MDRN
|
ID |
|
Emperador Inc
SGX:EMI
|
PH |
|
Boadicea Resources Ltd
ASX:BOA
|
AU |
|
Fermiere du Casino Municipal Cannes SA
PAR:FCMC
|
FR |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
I-nexus Global PLC
LSE:INX
|
UK |
|
S
|
Symphony Communication PCL
SET:SYMC
|
TH |
Shareholder Yield
Current shareholder yield for OXB is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
OXB Price
Oxford BioMedica PLC
| Average Annual Return | -0.92% |
| Standard Deviation of Annual Returns | 66.85% |
| Max Drawdown | -90% |
| Market Capitalization | 535.5m GBX |
| Shares Outstanding | 121 040 000 |
| Percentage of Shares Shorted | 50% |
OXB Return Decomposition
Main factors of price return
Stock Splits
OXB's latest stock split occurred on May 30, 2018
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, OXB traded at 14.92 per share. Afterward, the share price was about 700.
The adjusted shares began trading on May 30, 2018. This was stock split number 7 in OXB's history, following the previous one in Dec 14, 2010.
